Stories about research and scientific development at Mount Sinai
Mount Sinai Creates First Experimental Personalized Vaccine for a Variety of Cancers
The first personalized cancer vaccine administered to patients prior to evidence of spread but after surgery or a stem cell transplant, was shown to be safe, well tolerated, and potentially beneficial in preventing disease recurrence in a phase 1 clinical trial at The...
Mount Sinai Recognizes Lab Team for their Work during the COVID-19 Pandemic
COVID-19 brought numerous challenges for the hundreds of employees working in and with our medical laboratories across Mount Sinai Health System. They continued to show agility and dedication in meeting the changing needs of our community as the pandemic progressed....
Pregnancy and Antidepressants: Should You Avoid Taking Them?
Those who are pregnant or who may be thinking of getting pregnant may wonder if taking antidepressants could affect the heath of the child. New research from Mount Sinai offers some potentially important findings and shows that the underlying mental health of the...
Students Present Their Latest Studies at Medical Student Research Day
One hundred six poster presentations and four oral presentations capped off new research that was conducted by students at the Icahn School of Medicine at Mount Sinai and featured at Mount Sinai’s Fourth Annual Karen Zier, PhD, Medical Student Research Day, held over...
Artificial Intelligence Tools May Detect Abnormalities that Could Otherwise Be Missed
A patient’s electronic health record typically contains a trove of information that can be used to help predict and manage their future health needs. But much of that information is often composed of unstructured or fragmented data that first must be translated into...
Young, Asymptomatic People Can Get Reinfected With COVID-19 and Spread it More Than Once, Study Shows
A prospective study of 3,249 Marine recruits—who were mostly male and between the ages of 18 and 20—shows a significant risk of reinfection among those who have antibodies to SARS-CoV-2, the virus that leads to COVID-19. The study, posted on...
Researchers Identify a Promising New Antiviral Drug to Treat COVID-19
The search for better medical treatments for COVID-19 has led a team of scientists from the Icahn School of Medicine at Mount Sinai, with colleagues in San Francisco, to plitidepsin—a promising small molecule drug derived from a sea organism. When tested...
Sixth Annual Mount Sinai Innovation Awards
Individuals and teams from the Mount Sinai Health System were honored for advances in biomedical research, technology, and medicine at the sixth annual Mount Sinai Innovation Awards ceremony, a virtual event held Tuesday, December 8, 2020.Mount Sinai...
Mount Sinai Researchers Describe Viral Sanctuaries in the Gastrointestinal Tract of COVID-19 Patients
A new study published in the journal Nature by researchers at Mount Sinai in collaboration with two other labs at Rockefeller University and co-investigators from the California Institute of Technology and Weill Cornell Medicine describes for the first...